NCT02465489View on ClinicalTrials.gov

Comparison of Deferiprone Extended Release Tablets and Ferriprox Immediate Release Tablets in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Healthy
Interventions
DRUG

Deferiprone extended release

Deferiprone 1000 mg extended release tablet formulation

DRUG

Deferiprone immediate release

Ferriprox (deferiprone) 500 mg immediate release tablet formulation

Trial Locations (1)

H3P 3P1

Algorithme Pharma Inc., Mount Royal

Sponsors

Lead Sponsor

ApoPharma
All Listed Sponsors
lead

ApoPharma

INDUSTRY

NCT02465489 - Comparison of Deferiprone Extended Release Tablets and Ferriprox Immediate Release Tablets in Healthy Volunteers | Biotech Hunter | Biotech Hunter